Fernando O. Recio - Concepedia

Concepedia

Author

Fernando O. Recio

Roswell Park Comprehensive Cancer Center ORCID

Also Known As

F O Recio, F Recio, F. O. Recio, F. Recio, F.O. Recio, FERNANDO O. RECIO, Fernando O Recio, Fernando O. Recio, Fernando Recio

56

Publications

1.3K

Citations

21

H-Index

45

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center University of Vermont Memorial Sloan Kettering Cancer Center Gynecologic Oncology Group Rocky Mountain Cancer Centers

FO

About

Fernando O. Recio is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, obstetrics, and gynecology oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	694
2	Obstetrics	15	18	626
3	Pathology	4	4	169
4	Public Health	1	1	69
5	Anatomy	1	1	53

Fernando O. Recio

×

31

Publications

1.3K

Citations

21

H-Index

	Year	Citations
Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma Gamal H. Eltabbakh, M. Steven Piver, Ronald E. Hempling, Journal of Surgical Oncology	1999	142
A multicenter, single‐arm, open‐label, phase 2 study of apitolisib (GDC‐0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study) Vicky Makker, Fernando O. Recio, Ling Ma, Cancer	2016	96
Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy Fernando O. Recio, M. Steven Piver, Ronald E. Hempling, Cancer	1996	91
Endothelial Krüppel-like Factor 4 Regulates Angiogenesis and the Notch Signaling Pathway Andrew T. Hale, Hongmei Tian, Ejike Anih, Journal of Biological Chemistry	2014	90
Lymphvascular space involvement—A prognostic indicator in endometrial adenocarcinoma David Gal, Fernando O. Recio, Dragoslava Zamurovic, Gynecologic Oncology Endometrial AdenocarcinomaTumoral PathologyMedicineUterine ReceptivityGynecology	1991	86
Improvements in pelvic exenteration: Factors responsible for reducing morbidity and mortality Jeffrey M. Goldberg, M. Steven Piver, Ronald E. Hempling, Annals of Surgical Oncology Pelvic TraumaPelvic ProlapseReproductive HealthGynecologyOutcomes Research	1998	69
The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma David Gal, Fernando O. Recio, D. Zamurovic Cancer Surgical OncologyCancer ManagementPrognosisReproductive HealthGynecology	1992	63
The Inferior Gluteal Flap in the Difficult Vulvar and Perineal Reconstruction Thom R. Loree, Ronald E. Hempling, Gamal H. Eltabbakh, Gynecologic Oncology Gynecologic SurgeryVulvar DiseasesSoft Tissue SurgeryInferior Gluteal FlapMedicine	1997	53
Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial Heidi J. Gray, Benedict B. Benigno, Jonathan S. Berek, Journal for ImmunoTherapy of Cancer	2016	47
Correlation between Extreme Drug Resistance Assay and Response to Primary Paclitaxel and Cisplatin in Patients with Epithelial Ovarian Cancer Gamal H. Eltabbakh, M.Steven Piver, Ronald E. Hempling, Gynecologic Oncology Epithelial Ovarian CancerMedicinePrimary PaclitaxelPharmacologyMetronomic Therapy	1998	46

Page 1